Quest Diagnostics (DGX *) Stock Overview
Provides diagnostic testing and services in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
DGX * Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Quest Diagnostics Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$3,657.00 |
| 52 Week High | US$3,657.00 |
| 52 Week Low | US$3,132.50 |
| Beta | 0.65 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | 8.49% |
| 3 Year Change | n/a |
| 5 Year Change | 42.57% |
| Change since IPO | 79.60% |
Recent News & Updates
Recent updates
Shareholder Returns
| DGX * | MX Healthcare | MX Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | -0.6% |
| 1Y | 8.5% | 15.8% | 26.3% |
Return vs Industry: DGX * underperformed the MX Healthcare industry which returned 21.3% over the past year.
Return vs Market: DGX * underperformed the MX Market which returned 25.3% over the past year.
Price Volatility
| DGX * volatility | |
|---|---|
| DGX * Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.0% |
| Market Average Movement | 4.0% |
| 10% most volatile stocks in MX Market | 5.7% |
| 10% least volatile stocks in MX Market | 2.4% |
Stable Share Price: DGX *'s share price has been volatile over the past 3 months compared to the MX market.
Volatility Over Time: Insufficient data to determine DGX *'s volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1967 | 51,500 | Jim Davis | www.questdiagnostics.com |
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals.
Quest Diagnostics Incorporated Fundamentals Summary
| DGX * fundamental statistics | |
|---|---|
| Market cap | Mex$365.62b |
| Earnings (TTM) | Mex$17.05b |
| Revenue (TTM) | Mex$190.43b |
Is DGX * overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DGX * income statement (TTM) | |
|---|---|
| Revenue | US$11.04b |
| Cost of Revenue | US$7.36b |
| Gross Profit | US$3.68b |
| Other Expenses | US$2.69b |
| Earnings | US$988.00m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
Apr 21, 2026
| Earnings per share (EPS) | 8.93 |
| Gross Margin | 33.33% |
| Net Profit Margin | 8.95% |
| Debt/Equity Ratio | 80.3% |
How did DGX * perform over the long term?
See historical performance and comparisonDividends
Does DGX * pay a reliable dividends?
See DGX * dividend history and benchmarks| Quest Diagnostics dividend dates | |
|---|---|
| Ex Dividend Date | Apr 06 2026 |
| Dividend Pay Date | Apr 20 2026 |
| Days until Ex dividend | 11 days |
| Days until Dividend pay date | 3 days |
Does DGX * pay a reliable dividends?
See DGX * dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/16 07:53 |
| End of Day Share Price | 2026/03/04 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Quest Diagnostics Incorporated is covered by 36 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Eric Coldwell | Baird |
| Luke Sergott | Barclays |